Real-time enrollment status for this chronic inflammatory demyelinating polyneuropathy clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:55 AM UTC
| NCT Number | NCT06290141 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Sanofi |
| Last Updated on CT.gov | August 26, 2026 (5 days ago) |
As of August 31, 2026: Clinical trial NCT06290141 is currently recruiting participants. This phase3 study for chronic inflammatory demyelinating polyneuropathy is actively seeking new participants at 33 locations across the United States. The study is sponsored by Sanofi. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06290141 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06290141 was last updated 5 days ago (August 26, 2026). HelloStudys verifies this status automatically.